^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GutSeer assay

    Company:
    Singlera Genomics
    Type:
    CE-IVD (Old IVDD)
    Related tests:

    Details

    Evidence
    News
    Introducing GutSeer®, a groundbreaking noninvasive test revolutionizing the early detection and localization of gastrointestinal (GI) cancers. GutSeer® offers cost-effective blood-based assay leveraging cell-free DNA (cfDNA) methylation and fragmentation signatures. Our innovative approach relies on a single targeted DNA methylation sequencing panel, comprising 1656 target regions, designed for early detection across five major GI cancers: colorectal (CC), gastric (GC), liver (LC), esophageal (EC), and pancreatic cancer (PC).
    Cancer:
    Solid Tumor
    Method:
    CfDNA Methylation